U.S. Breast Cancer Diagnostics Market Size & Outlook
U.S. breast cancer diagnostics market, 2018-2030 (US$M)
Related Markets
U.S. breast cancer diagnostics market highlights
- The U.S. breast cancer diagnostics market generated a revenue of USD 7,235.3 million in 2023 and is expected to reach USD 12,264.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
Breast cancer diagnostics market data book summary
| Market revenue in 2023 | USD 7,235.3 million |
| Market revenue in 2030 | USD 12,264.2 million |
| Growth rate | 7.8% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
| Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 41.8% of the global breast cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. breast cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,258.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Diagnostics Market Scope
Breast Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. breast cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61.57% in 2023. Horizon Databook has segmented the U.S. breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the largest market for breast cancer diagnostics owing to local presence of key manufacturers in the country, high awareness & adoption, and well-established healthcare infrastructure. Increasing incidence of breast cancer in the country is one of the major factors expected to boost market growth.
According to estimates published in the Breast Cancer Facts & Figures 2020-2021 report by the American Cancer Society, in 2021, around 281,550 invasive cases and approximately 43,600 deaths were reported among women in the U.S. In addition, it was published that around 1 in 8 women will be diagnosed with the disease in their lifetime.
Moreover, the commercialization of newly launched products such as VENTANA HER2 Dual ISH and Foundation One CDx in the country is estimated to drive the market over the forecast period. As of 2020, there were 17 approved companion diagnostic tests for breast cancer in the country.
Reasons to subscribe to U.S. breast cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. breast cancer diagnostics market databook
-
Our clientele includes a mix of breast cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. breast cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. breast cancer diagnostics market size, by end use, 2018-2030 (US$M)
U.S. Breast Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
